Log In
Print
BCIQ
Print
Print this Print this
 

Epoetin alfa (JR-013)

  Manage Alerts
Collapse Summary General Information
Company JCR Pharmaceuticals Co. Ltd.
DescriptionBiosimilar recombinant human erythropoietin (EPO) rDNA origin
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Latest Stage of DevelopmentMarketed
IndicationAnemia
Partner

GlaxoSmithKline plc; Kissei Pharmaceutical Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today